Skip to main content
TipRanks
Go Ultimate75% OFF

Oxford BioMedica (OXOA) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

OXOA Analyst Ratings

Moderate Buy
3Ratings
2Buy1Hold0Sell
Based on 3 analysts giving stock ratings to Oxford BioMedica in the past 3 months

OXOA Stock 12 Month Forecast

€9.28▲(42.75% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Oxford BioMedica in the last 3 months. The average price target is EUR 9.28 with a high forecast of EUR 10.79 and a low forecast of EUR 7.13. The average price target represents a 42.75% change from the last price of EUR 6.50.
Highest Price Target€10.79Average Price Target€9.28Lowest Price Target€7.13

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:OXOA
Price TargetArticle
Jefferies€9.91buy52.52%UpsideReiterated10/26/26
RBC Capital€10.79buy65.99%UpsideReiterated09/28/26
Deutsche Bank €7.13hold9.74%UpsideReiterated09/02/26
Stifel Nicolaus€11.39buy75.21%UpsideReiterated03/11/26
J.P. Morgan€4.80→€6.59hold1.44%UpsideReiterated12/08/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
HROWHarrow Health
PLSEPulse Biosciences
DFTXDefinium Therapeutics
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Oxford BioMedica

3 Months
Charles Weston
Charles WestonRBC Capital
Success Rate17/28 ratings generated profit
61%
Average Return
+4.23%

Copying Charles Weston's trades and holding each position for 3 Months would result in 60.71% of your transactions generating a profit, with an average return of +4.23% per trade.

1 Year
Charles Weston
Charles WestonRBC Capital
Success Rate12/28 ratings generated profit
43%
Average Return
+7.31%

Copying Charles Weston's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of +7.31% per trade.

2 Years
Charles Weston
Charles WestonRBC Capital
Success Rate10/28 ratings generated profit
36%
Average Return
+0.16%

Copying Charles Weston's trades and holding each position for 2 Years would result in 35.71% of your transactions generating a profit, with an average return of +0.16% per trade.

OXOA Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for OXOA
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy23454
Buy11000
Hold01221
Sell00000
Strong Sell00000
total35675

In the current month, OXOA has received 4 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. OXOA average Analyst price target in the past 3 months is 9.28.

OXOA Financial Forecast

€-2€-1.25€-0.5€0.25€1Q2 2025Q2 2026Q4 2026
High€0.00
Consensus€-0.03
Low€-0.05

OXOA Earnings Forecast

Next quarter’s earnings estimate for OXOA is -EUR 0.03 with a range of -EUR 0.05 to EUR 0.00. The previous quarter’s EPS was -EUR 0.35. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€85.2M€95M€104.8M€114.6M€124.4MQ2 2025Q2 2026Q4 2026
High€124M
Consensus€124M
Low€123M

OXOA Sales Forecast

Next quarter’s sales forecast for OXOA is EUR 123.85M with a range of EUR 123.27M to EUR 124.43M. The previous quarter’s sales results were EUR 92.85M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

OXOA Stock Forecast FAQ

What is DE:OXOA’s average 12-month price target, according to analysts?
Based on analyst ratings, Oxford BioMedica’s 12-month average price target is €9.28.
What is DE:OXOA’s upside potential, based on the analysts’ average price target?
Oxford BioMedica has 42.75% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Oxford BioMedica a Buy, Sell or Hold?
Oxford BioMedica has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
What is Oxford BioMedica’s share price target?
The average share price target for Oxford BioMedica is €9.28. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €10.79, and the lowest forecast is €7.13. The average share price target represents a 42.75% increase from the current price of €6.5.
What do analysts say about Oxford BioMedica?
Oxford BioMedica’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of Oxford BioMedica?
To buy shares of DE:OXOA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.